Ironwood Pharmaceuticals, Inc. IRWD NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

53/100

0/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Ironwood Pharmaceuticals, Inc. (IRWD), dont 23 achats et 25 ventes. Le total des achats d'initiés s'élève à $62.26K et le total des ventes d'initiés à $1.84M.

Les initiés notables ayant une activité récente comprennent Denner Alexander J, Mccourt Thomas A, Shetzline Michael. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — IRWD

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-17	Denner Alexander J	Director	Vente Informative	5,800	$3.31	$19.2K	9,188,635
2026-03-13	Denner Alexander J	Director	Attribution de RSU	4,451	-	-	256,309
2026-03-10	Mccourt Thomas A	Chief Executive Officer	Attribution de RSU	409,836	-	-	1,898,838
2026-03-10	Shetzline Michael	SVP, CMO, Head-res&drug	Attribution de RSU	136,612	-	-	658,037
2026-03-10	Silver Ronald	Principal Accounting Officer	Attribution de RSU	163,934	-	-	416,570
2026-03-10	John Minardo	Chief Legal Officer	Attribution de RSU	136,612	-	-	500,498
2026-03-10	Martini Gregory S.	Chief Financial Officer	Attribution de RSU	136,612	-	-	297,213
2026-03-10	Gaskins Tammi L	Chief Commercial Officer	Attribution de RSU	136,612	-	-	350,350
2026-02-24	Mccourt Thomas A	Chief Executive Officer	Vente Informative	103,526	$3.66	$378.91K	1,489,002
2026-02-24	Shetzline Michael	SVP, CMO, Head-res&drug	Achat Informatif	17,012	$3.66	$62.26K	521,425
2026-02-24	Silver Ronald	Principal Accounting Officer	Vente Informative	12,621	$3.66	$46.19K	252,636
2026-02-24	John Minardo	Chief Legal Officer	Vente Informative	19,053	$3.66	$69.73K	363,886
2026-02-24	Martini Gregory S.	Chief Financial Officer	Vente Informative	11,457	$3.66	$41.93K	160,601
2026-02-24	Gaskins Tammi L	Chief Commercial Officer	Vente Informative	11,239	$3.66	$41.13K	213,738
2026-02-23	Mccourt Thomas A	Chief Executive Officer	Vente Informative	94,757	$3.81	$361.02K	1,592,528
2026-02-23	Shetzline Michael	SVP, CMO, Head-res&drug	Vente Informative	15,570	$3.81	$59.32K	538,437
2026-02-23	Silver Ronald	Principal Accounting Officer	Vente Informative	11,552	$3.81	$44.01K	265,257
2026-02-23	John Minardo	Chief Legal Officer	Vente Informative	17,439	$3.81	$66.44K	382,939
2026-02-23	Martini Gregory S.	Chief Financial Officer	Vente Informative	10,487	$3.81	$39.96K	172,058
2026-02-23	Gaskins Tammi L	Chief Commercial Officer	Vente Informative	10,287	$3.81	$39.19K	224,977
2026-01-05	Silver Ronald	Principal Accounting Officer	Vente Informative	35,416	$4.60	$162.91K	276,809
2025-12-15	Denner Alexander J	10 Percent Owner	Attribution de RSU	4,178	-	-	251,858
2025-11-17	Gaskins Tammi L	Chief Commercial Officer	Vente Informative	6,016	$3.32	$19.97K	235,264
2025-09-15	Denner Alexander J	10 Percent Owner	Attribution de RSU	11,718	-	-	247,680
2025-08-11	Silver Ronald	Principal Accounting Officer	Vente Informative	2,846	$0.84	$2.39K	276,809
2025-08-11	John Minardo	Chief Legal Officer	Vente Informative	7,754	$0.84	$6.51K	400,378
2025-08-11	Martini Gregory S.	Chief Financial Officer	Vente Informative	1,265	$0.84	$1.06K	182,545
2025-08-11	Gaskins Tammi L	Chief Commercial Officer	Vente Informative	1,316	$0.84	$1.11K	241,280
2025-06-13	Denner Alexander J	10 Percent Owner	Attribution de RSU	24,193	-	-	235,962
2025-06-10	Denner Alexander J	10 Percent Owner	Attribution de RSU	45,000	-	-	211,769
2025-06-10	Currie Mark G	Director	Attribution de RSU	45,000	-	-	613,419
2025-06-10	Mchugh Julie	Director	Attribution de RSU	45,000	-	-	208,839
2025-06-10	Shepard Jay	Director	Attribution de RSU	45,000	-	-	171,555
2025-06-10	Dreyfus Andrew	Director	Attribution de RSU	45,000	-	-	228,313
2025-06-10	Kessler Marla L	Director	Attribution de RSU	45,000	-	-	165,883
2025-06-10	Duane Jon R	Director	Attribution de RSU	45,000	-	-	190,339
2025-06-10	Moukheibir Catherine	Director	Attribution de RSU	45,000	-	-	117,944
2025-05-20	Mccourt Thomas A	Chief Executive Officer	Attribution de RSU	540,000	-	-	1,687,281
2025-05-16	Mccourt Thomas A	Chief Executive Officer	Vente Informative	13,353	$0.58	$7.74K	1,147,281
2025-05-16	Gaskins Tammi L	Chief Commercial Officer	Vente Informative	2,563	$0.58	$1.49K	242,596
2025-04-02	Denner Alexander J	10 Percent Owner	Attribution de RSU	10,416	-	-	166,769
2025-03-11	Gaskins Tammi L	Chief Commercial Officer	Inconnu	-	-	-	245,159
2025-02-10	Mccourt Thomas A	Chief Executive Officer	Vente Informative	139,064	$1.76	$244.75K	1,160,634
2025-02-10	Shetzline Michael	SVP, CMO, Head-res&drug	Vente Informative	41,269	$1.76	$72.63K	554,007
2025-02-10	Silver Ronald	Principal Accounting Officer	Vente Informative	12,048	$1.76	$21.2K	279,655
2025-02-10	John Minardo	Chief Legal Officer	Vente Informative	38,938	$1.76	$68.53K	408,132
2025-02-10	Martini Gregory S.	Chief Financial Officer	Vente Informative	12,052	$1.76	$21.21K	183,810
2025-01-27	Silver Ronald	Principal Accounting Officer	Attribution de RSU	133,333	-	-	291,703
2025-01-27	Martini Gregory S.	Chief Financial Officer	Inconnu	1,587	$12.95	$20.55K	-
2025-01-27	Martini Gregory S.	Chief Financial Officer	Attribution de RSU	111,111	-	-	195,862

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration